CLN — Celon Pharma SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-5.59	-15.1	-36.4	-20	-39.4
Depreciation
Non-Cash Items	0.767	3.63	-4.62	-8.27	-13.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital	44.8	14.1	-7.73	-30.1	-10.5
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	71.7	44	-4.7	-8.31	-11.3
Capital Expenditures	-99.5	-41.4	-33.9	-32.8	-22.8
Purchase of Fixed Assets
Other Investing Cash Flow Items	46.2	-79.7	2.43	11.2	15.3
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-53.3	-121	-31.5	-21.6	-7.49
Financing Cash Flow Items	-0.586	-14.3	-1.5	-2.62	-2.19
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4.25	181	-28.7	-20.6	13.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	22.7	104	-64.9	-50.5	-5.51